Capricor Therapeutics Inc (NASDAQ: CAPR) kicked off on Monday, down -8.87% from the previous trading day, before settling in for the closing price of $6.88. Over the past 52 weeks, CAPR has traded in a range of $3.52-$23.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 11.01% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -66.26%. With a float of $40.15 million, this company’s outstanding shares have now reached $45.68 million.
In an organization with 160 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -329.9%, and the pretax margin is -317.13%.
Capricor Therapeutics Inc (CAPR) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Capricor Therapeutics Inc is 12.16%, while institutional ownership is 40.31%. The most recent insider transaction that took place on Sep 20 ’24, was worth 14,999,998. In this transaction 10% Owner of this company bought 2,798,507 shares at a rate of $5.36, taking the stock ownership to the 7,090,351 shares.
Capricor Therapeutics Inc (CAPR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -66.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 85.74% during the next five years compared to 11.01% growth over the previous five years of trading.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Take a look at Capricor Therapeutics Inc’s (CAPR) current performance indicators. Last quarter, stock had a quick ratio of 6.55. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.42, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Let’s dig in a bit further. During the last 5-days, its volume was 2.47 million. That was better than the volume of 2.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 4.10%.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 1.98%, which indicates a significant increase from 1.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.74 in the past 14 days, which was lower than the 1.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.04, while its 200-day Moving Average is $13.66.
